CIK 0001478320
- Large accelerated filer
Adaptive Biotechnologies Corp
Sign in to watch- Ticker
- ADPT
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- WA
- Entity type
- Operating
- EIN
- 270907024
- Phone
- +1 206-659-0067
- Business address
- 1165 EASTLAKE AVE E, SEATTLE, WA, 98109
- Former names
- Adaptive TCR Corp
- 4 Planned sale President and COO sold 69,061 shares at an average $14.60 ($1,008,622)
- 4 Planned sale President and COO sold 57,180 shares at an average $14.45 ($826,251)
- 4 Planned sale President and COO sold 57,180 shares at an average $13.26 ($758,108)
- 4 Planned sale Chief People Officer sold 22,564 shares at $15.07 ($340,039)
- 4 Planned sale Chief Scientific Officer sold 10,000 shares at $14.85 ($148,500)
- 4 Planned sale CEO and Chairman sold 120,595 shares at an average $14.65 ($1,766,839)
- 4 Planned sale President and COO sold 69,061 shares at an average $14.34 ($990,503)
- 4 Planned sale President and COO sold 38,120 shares at an average $14.53 ($553,693)
- 4 Planned sale President and COO sold 57,180 shares at an average $13.14 ($751,303)
- 4 Planned sale President and COO sold 57,180 shares at an average $14.03 ($802,235)
- 4 Planned sale President and COO sold 57,180 shares at an average $13.46 ($769,643)
- 4 Planned sale President and COO sold 57,180 shares at an average $13.33 ($762,209)
- 4 Planned sale President and COO sold 179,703 shares at an average $13.21 ($2,374,058)
- 4 Open-market sale Director sold 15,394 shares at $13.91 ($214,131)
- 4 Planned sale Chief People Officer sold 30,593 shares at $14.08 ($430,749)
- 4 Open-market sale Chief Commercial Officer, MRD sold 41,338 shares at $13.17 ($544,421)
- 4 Open-market sale Chief Commercial Ofc Imm Med sold 63,103 shares at $13.17 ($831,067)
- 4 Open-market sale Chief Financial Officer sold 18,672 shares at $13.17 ($245,910)
- 4 Open-market sale Chief Scientific Officer sold 470,266 shares at $13.17 ($6,193,403)
- 4 Open-market sale CEO and Chairman sold 470,167 shares at $13.17 ($6,192,099)
Page 3 of 28 · 544 filings